Document is current

Article History

Received: 10 September 2025

Accepted: 17 December 2025

First Online: 13 January 2026

Declarations

:

: Dr. Richman has received funding from the National Cancer Institute, the American Medical Association for editoral services, and the Centers for Medicare and Medicaid Services outside of this work. Dr. Fendrick reported directing the University of Michigan Center for Value-Based Insurance design; providing consulting services to AbbVie, Centivo, Community Oncology Association, Covered California, Eebu Health, Elektra Health, Emblem Health, Employee Benefit Research Institute, Exact Sciences, GRAIL, Health Corum, Johnson & Johnson, Medtronic, MedZed, Merck and Company, Mother Goose Health, Phathom Pharmaceuticals, Proton Intelligence, RA Capital, Sempre Health, Sera Health, Silver Fern Healthcare, Virginia Center for Health Innovation, Washington Health Benefit Exchange, Wellth, and Zansors; holding equity interest in Health Corum, Mother Goose Health, Sempre Health, Silver Fern HealthCare, Wellth, and Zansors; receiving research support from the Agency for Healthcare Research and Quality, West Health Policy Center, Arnold Ventures, National Pharmaceutical Council, Patient-Centered Outcomes Research Institute, Pharmaceutical Research and Manufacturers of America, and the Centers for Medicare and Medicaid Services; serving as co-editor in chief for the American Journal of Managed Care; previously serving as a member of the Medicare Evidence Development and Coverage Advisory Committee; and maintaining a partnership at VBID Health.

Free to read: This content has been made available to all.